Swiss medical regulators have approved a new malaria treatment for infants, offering hope to many in Africa KAMPALA, Uganda - ...

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, ...

In a press release, the organisation said the news was “a major step forwards” in the fight against the disease.

A genomic study of malaria samples from Tanzania and Zanzibar found mutations connected to artemisinin partial resistance, ...

The patient has not traveled outside of the U.S., so officials are looking into how he could have acquired the mosquito-borne ...

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or ...

Malaria killed almost 600,000 people in 2023, as cases rose for the fifth consecutive year, according to a new report from the World Health Organization (WHO).

In the horn of Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, which could dramatically worsen malaria's impact if partner drugs ...

Analysis - The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025 ...